Maximize Your Impact at DPHARM 2026
DPHARM 2026, scheduled for September 15th at the Sheraton Boston in Massachusetts, is one of the most strategic events in clinical research innovation. Known for advancing disruptive ideas in drug development processes, this event brings together clinical operations leaders, digital health pioneers, biopharma executives, and innovation strategists from top pharmaceutical companies and biotech startups.
This is where decisions are made about trial optimization, vendor partnerships, budget allocations, and technology adoption. Attendees typically include VPs and Directors of Clinical Operations, R&D, Patient Engagement, and Digital Trials, offering a unique opportunity to influence next-year planning cycles. Early outreach can set up high-value, in-person conversations with decision-makers who drive vendor selection and shape protocol innovation strategies. With Vendelux’s enriched attendee list, your team gains access to in-depth insights about who’s attending and where to focus outreach for scalable deal-making.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Teams focused on life sciences, technology platforms, or patient engagement services can use this list to drive meaningful engagement ahead of DPHARM 2026. For sales and partnerships, the enriched conference attendee list allows segmentation by company size, trial phase responsibilities, and innovation investment profiles—perfect for identifying who is testing new digital products or looking for CRO partnerships.
Marketing teams can tailor email sequences and digital campaigns based on the pipeline needs of specific pharma companies attending. Whether scheduling pre-conference demos or aligning messaging to upcoming initiatives, this data helps get more meetings booked with budget holders. RevOps teams can map sales territories around organizations that are actively scaling decentralized trials or sourcing automation tools. After the event, teams can continue the outreach with follow-ups tailored to on-site conversations and strategic priorities. Vendelux enables smarter, more informed engagement across the full funnel using attendee data that aligns your message to what buyers actually care about.
Timing Is Everything
DPHARM 2026 will take place on September 15, 2026. In an industry where planning cycles are long and annual vendor reviews happen once a year, timing outreach before the event is key to securing attention and budget.
By accessing the enriched attendee list early through Vendelux, your team can start reaching out to trial innovation leads months in advance. This proactive approach boosts visibility ahead of competing vendors who only engage during the event itself. Early outreach also helps your organization shape on-site discussions and position meetings around budget windows that often close by Q4. Closing gaps between initial touchpoints and face-to-face meetings begins now.
What’s Included in the DPHARM 2026 Attendee List?
Vendelux provides visibility into executives expected to attend DPHARM 2026 through a combination of organizer-released information and predictive models tracking industry behavior. Clients can upload their own target account lists to receive matches from the attendee database.
The enriched attendee list includes each person’s first and last name, current job title, company name, company website, city, state, country, LinkedIn profile, verified email address, and phone number when available.
Where Is DPHARM 2026?
Sheraton Boston | Boston, Massachusetts, United States
When Is DPHARM 2026?
September 15, 2026
What Type of Event Is DPHARM 2026?
DPHARM 2026 is a leading conference focused on innovation in clinical trials and drug development within the biopharmaceutical sector. The event features mainstage presentations, executive panels, and curated networking opportunities designed for forward-thinking professionals working on patient-centric trial models and digital enablement.
How Many People Attend DPHARM 2026?
DPHARM 2026 is expected to host over 600 attendees from major pharmaceutical companies, biotech firms, and clinical providers across North America and Europe. The audience is primarily composed of senior-level professionals including department heads, vice presidents, and innovation leads.
